Drug Trial Radar · NCT06832410
An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant
Last checked: Nov 19, 2026Latest source record: Mar 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
10
Planned (sponsor's estimate)
Start
Mar 31, 2025
Primary completion
Sep 17, 2026
Study completion Sep 17, 2027
Sponsor
- Lead sponsor
- Vertex Pharmaceuticals IncorporatedVertex Pharmaceuticals (VRTX)
- Sponsor type
- Industry
- First posted
- Feb 18, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will evaluate the efficacy, safety, and tolerability of VX-880 in participants with Type 1 Diabetes (TID) with a kidney transplant.
Conditions
- Type 1 Diabetes
- Kidney Transplant
Interventions
Biological/VaccineBiological
Infused into the hepatic portal vein.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of Participants who are Insulin IndependentTime frame: At 1 year After VX-880 infusion
Locations
7 sites in 3 countries. Site status is shown where the registry gives one.
Perelman Center for Advanced Medicine - Endocrinology
Philadelphia, Pennsylvania · Recruiting
Montefiore Clinical and Translational Research Center - Endocrinology
Pittsburgh, Pennsylvania · Recruiting
UW University Hospital - Endocrinology
Madison, Wisconsin · Recruiting
Toronto General Hospital - Endocrinology
Toronto, Canada · Recruiting
Vancouver General Hospital - Gordon and Leslie Diamond Health Care Centre
Vancouver, Canada · Recruiting
King Abdullah International Medical Research Center (KAIMRC) - Riyadh - Endocrinology
Riyadh, Saudi Arabia · Recruiting
King Faisal Specialist Hospital & Research Centre - Riyadh - Endocrinology
Riyadh, Saudi Arabia · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.